MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
Go back to MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.17 +0.11 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $2.51 | |||
| Open | $4.00 | 52 Week Low | $0.41 | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $-0.64 | |||
| Volume | 3,205,639 | |||||
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.17 +0.11 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $2.51 | |||
| Open | $4.00 | 52 Week Low | $0.41 | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $-0.64 | |||
| Volume | 3,205,639 | |||||

